Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-25-006800
Filing Date
2025-03-03
Accepted
2025-03-03 17:19:05
Documents
16
Effectiveness Date
2025-03-03

Document Format Files

Seq Description Document Type Size
1 S-8 ef20044742_s8.htm S-8 56704
2 EXHIBIT 5.1 ef20044742_ex5-1.htm EX-5.1 16040
3 EXHIBIT 23.2 ef20044742_ex23-2.htm EX-23.2 3196
4 ef20044742_ex107.htm   iXBRL EX-FILING FEES 18771
5 image00001.jpg GRAPHIC 3034
  Complete submission text file 0001140361-25-006800.txt   234824

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20044742_ex107_htm.xml XML 7411
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285520 | Film No.: 25699615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)